By Sylvie Riou-Milliot THE Reading 8 min. Subscribers
This autoimmune disease manifests as patches of depigmentation on the body. A condition that is often stigmatized and poorly managed by medicine. A new molecule allows melanocytes to recolonize the skin and recolor it. Here's how.
Winnie Harlow, a model with vitiligo, walks the runway in Christian Siriano Fall/Winter 2025 at Chelsea Industrial on February 6, 2025 in New York City.
JP Yim / GETTY IMAGES NORTH AMERICA / Getty Images via AFP
This article is taken from the monthly Sciences et Avenir n°937, dated March 2025.
“ Some people have black skin, others have mixed skin, I have both. Canadian model Winnie Harlow is fighting with unprecedented courage for the inclusion of vitiligo patients. This autoimmune dermatological disease, defined by patches of depigmentation of the skin (and sometimes also of the hair), is not uncommon, affecting 1 to 2 people with vitiligo in the general population. But it remains stigmatizing.
English 
French